72 results
8-K
EX-99.1
BRKR
Bruker Corp
9 Jan 12
Results of Operations and Financial Condition
12:00am
financial guidance, or as Bruker’s specific FY2012 financial goals. INNOVATION WITH INTEGRITY
3 © Copyright 2012 Bruker Corporation. Financial Goals: Fast … Markets Operational Excellence Initiative On-Going Focus on Products, Customer Collaborations and Major Innovation Proven Innovator, Extensive IP & Product
8-K
EX-99.1
BRKR
Bruker Corp
8 Aug 11
Results of Operations and Financial Condition
12:00am
these forward-looking statements other than as required by law. INNOVATION WITH INTEGRITY
© Copyright 2011 Bruker Corporation. 3 Premier Brand … Growth Experienced & Empowered Management Teams Focus on Science, Customer Collaborations and Major Innovation Proven Innovator, Extensive Proprietary IP
8-K
EX-99.1
BRKR
Bruker Corp
12 Jan 11
Results of Operations and Financial Condition
12:00am
(draft v2.5 10/30) 1 INNOVATION WITH INTEGRITY Bruker Corporation (BRKR) 29th Annual J.P. Morgan Healthcare Conference January 12, 2011 Frank Laukien … -looking statements other than as required by law. INNOVATION WITH INTEGRITY
Premier Brand with Leading Market Share in Key Markets High-Performance
8-K
EX-99.1
BRKR
Bruker Corp
10 May 19
Bruker Announces New $300 Million Share Repurchase Authorization and Quarterly Dividend
7:11am
capital allocation strategy of prioritizing investments and innovation that grow the business over the long term, including our high growth Project … at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity
8-K
EX-99.1
BRKR
Bruker Corp
16 Mar 22
Bruker Appoints Philip Ma to its Board of Directors
9:55am
Accelerate 2.0 initiatives in multiomics life science and clinical research tools. Philip shares our ‘innovation with integrity’ entrepreneurial culture … life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved
8-K
EX-99.1
y78g 21re
2 May 24
Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech
7:00am
8-K
EX-99.1
e9mkyzfp4lk cp6wu6zm
15 May 23
Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board Declares Quarterly Dividend
4:00pm
8-K
EX-99.1
4lbaqf3gf6f
6 Jun 18
Bruker Corporation Appoints Gerald Herman as Chief Financial Officer
7:08am
DEFA14A
z0zf to103imawd
5 Jun 06
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
jpw8u9l5
2 May 19
Bruker Reports First Quarter 2019 Financial Results
4:18pm
8-K
EX-99.1
1psk eazjbt
13 May 21
Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board also Declares Quarterly Dividend
8:07am
8-K
EX-99.1
gcu p20y7w5g1w
5 Mar 20
Bruker Receives Notification from Nasdaq Related to Delayed Annual Report on Form 10-K
5:15pm
8-K
EX-99.1
z4ubn4 prbwq9c
8 Sep 20
Bruker Appoints Bonnie H. Anderson to its Board of Directors
7:05am
DEFA14A
y6mtkrhk23x1u61
11 May 20
Additional proxy soliciting materials
8:00am
8-K
EX-99.1
nodzi1f
22 Oct 03
Company to Consolidate Certain Production Sites While Strengthening Sales and Customer Support
12:00am
8-K
EX-99.1
ls8sh
22 Apr 24
Bruker to Acquire the NanoString Business in an Asset Deal
7:16am
8-K
EX-99.1
2q3mkk9
13 Feb 24
Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
7:39am
8-K
EX-99.1
xk1er c1msvhclu
13 Apr 21
Bruker Announces First Quarter 2021 Preliminary Revenue
4:20pm
SC TO-C
EX-99.1
h3js8i
17 Aug 23
Information about tender offer
4:05pm
8-K
EX-99.1
fd75 p388
17 Jun 21
Bruker Updates FY 2021 Guidance and Provides Medium Term Outlook at Virtual Investor Day
8:00am